Cardiovascular Risk in Women with Diabetes in a Single Centre Study
Abstract
Background: Among both men and women, diabetes is one of the strongest cardiovascular risk factors. It has been established that type 1 and type 2 diabetes, which both raise the risk of cardiovascular disease (CVD) in women, are more common. Objectives: The aim of the study was to investigate the impact of cardiovascular disease (CVD) Risk in women with diabetes among patients. Methods: This study was a cross-sectional, observational study contained both descriptive and analytical components. The study comprised 160 purposively selected diabetic patients over 45 years old diagnosed from January 2020 to December 2020 in Bangladesh admitted in BIRDEM hospital, Dhaka. After reviewing and rechecking the data, SPSS version 26 was used to do statistical analysis. The level for statistical significance was set at 0.05. Results: Most of the patients belong to 40-49 years age group. Smoke status of the population where 4(2.5%) were current status, 148(92.5%) were never and 8(5.0%) ware former smoker. Most of the patients belong to 148 women of never smoke of this population. Most of the patients belong to 127 women of high-risk of this population. Large scale clinical findings of cardiovascular diseases of the patients Mean±SD HbA1c mmol/mol of 54.6±11.6 and low scale clinical findings of cardiovascular diseases of the patients Mean±SD HDL-c mmol/l of 1.2±0.3. Drugs of the population where 108(67.5%) were Glucose-lowering drugs, 57.5(92.0%) were Lipid-lowering drugs and 108(67.5%) ware Antihypertensive drugs. Most of the patients belong to 108 women using Glucose-lowering drugs and Antihypertensive drugs. Conclusion: The study shows a high prevalence of multiple cardiovascular risk factors among participants with diabetes
Downloads
References
Stamler J, Vaccaro O, Neaton JD, Wentworth D, Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes care. 1993 Feb 1;16(2):434-44.
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Bmj. 2000 Aug 12;321(7258):405-12.
Claudi T, Midthjell K, Holmen J, Fougner K, Krüger Ø, Wiseth R. Cardiovascular disease and risk factors in persons with type 2 diabetes diagnosed in a large population screening: The Nord‐Trøndelag Diabetes Study, Norway. Journal of internal medicine. 2000 Dec;248(6):492-500.
Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, Gatling W, Bingley PJ, Patterson CC. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 2003 Jun;46(6):760-5.
Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe. The EURODIAB prospective complications study. Diabetes Care 2004;27(2):530-7.
Huxley R, Barzi F, Woodward M. Excess risk associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332:73e8.
Marks JB, Raskin P. Cardiovascular risk in diabetes: a brief review. Journal of Diabetes and its Complications. 2000 Mar 1;14(2):108-15.
Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S. Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007 Feb 6;115(5):e69-171.
Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, Fabunmi RP, Kwan J, Mills T, Simpson SL. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. circulation. 2005 Feb 1;111(4):499-510.
Orchard TJ. The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin dependent diabetes mellitus. Ann Med 1996;28: 323-33.
Lee WI, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary heart disease in women and men: a meta-analysis of prospective studies. Diabetes Care 2000;23:962-8.
Kanaya A, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus. Arch Intern Med; 2002:1737-45.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): caseecontrol study. Lancet 2004;364:937-52.
Akhtar S, Nasir JA, Sarwar A, Nasr N, Javed A, Majeed R, Salam MA, Billah B. Prevalence of diabetes and pre-diabetes in Bangladesh: a systematic review and meta-analysis. BMJ open. 2020 Sep 1;10(9):e036086.
Alsaadon H, Afroz A, Karim A, Habib SH, Alramadan MJ, Billah B, Shetty AN. Hypertension and its related factors among patients with type 2 diabetes mellitus–a multi-hospital study in Bangladesh. BMC Public Health. 2022 Dec;22(1):1-0.
Mohan V, Pradeepa R. Epidemilogy of diabetes in different Regions of India. Health administrator. 2009;22(1-2):1-8.
Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World journal of diabetes. 2015 Oct 10;6(13):1246.
Nargis N, Thompson ME, Fong GT, Driezen P, Hussain AG, Ruthbah UH, Quah AC, Abdullah AS. Prevalence and patterns of tobacco use in Bangladesh from 2009 to 2012: evidence from International Tobacco Control (ITC) Study. PloS one. 2015 Nov 11;10(11):e0141135.
Danaei G, Lu Y, Singh GM, Carnahan E, Stevens GA, Cowan MJ, Farzadfar F, Lin JK, Finucane MM, Rao M, Khang YH. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes & Endocrinology. 2014.
Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovascular diabetology. 2018 Dec;17(1):1-9.
Khan N, Oldroyd JC, Hossain MB, Islam RM. Awareness, treatment, and control of diabetes in Bangladesh: evidence from the Bangladesh Demographic and Health Survey 2017/18. International Journal of Clinical Practice. 2021 Jul 14;2022.
Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R. International consensus on use of continuous glucose monitoring. Diabetes care. 2017 Dec 1;40(12):1631-40.
Gakidou E, Mallinger L, Abbott-Klafter J, et al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ. 2011;89(3):172-183.
Khan AB, Ghazanfar MS, Khan SI. Application of phonetic encoding for analyzing similarity of patient's data: Bangladesh perspective. In2017 IEEE Region 10 Humanitarian Technology Conference (R10-HTC) 2017 Dec 21 (pp. 664-667). IEEE.
Islam MM, Rahman MJ, Roy DC, Maniruzzaman M. Automated detection and classification of diabetes disease based on Bangladesh demographic and health survey data, 2011 using machine learning approach. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020 May 1;14(3):217-9.
